C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
POSAF Equity

POSAF

OTCMKTS · POSAF

$0.07
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
46/100 composite
Fundamentals49
Regulatory58
Market40
Editorial30
Composite · trailing 12 months

CIN rates POSaBIT Systems Neutral with conviction at two out of five, reflecting a composite near 46 points and an uneven pillar profile. Regulatory is the strongest contribution at 58, supported by an 80 jurisdiction-posture subscore and an 80 enforcement subscore. Fundamentals contribute 49, with exceptional gross-margin economics offset by contracting revenue, negative operating profitability, limited scale, and a stretched financial condition. Market contributes 40 because institutional pricing feeds carry no available quote, restricting price-based confirmation. Editorial contributes 30, consistent with no newsroom or brief activity in CIN newsroom coverage. The resulting band appropriately captures strong regulatory positioning without granting credit for operating momentum or market validation that the underlying data do not deliver.

Licensed fundamentals data show year-over-year revenue contraction of 25%, while gross margin remained unusually high at approximately 82.6%. That spread did not translate into operating profitability: operating margin was negative 10.3%, net income was a loss of roughly $1.16 million, and EBITDA was negative by about $1.15 million. The 69 operating-margin subscore and 54.3 cash-runway subscore offer partial fundamental support, but the zero market-cap tier subscore and 25 revenue-growth subscore constrain the pillar. A cash-burn ratio near 14.2% reinforces the stretched financial condition rather than indicating balance-sheet durability. Primary regulatory filings show no recorded events during either the past 90 or 180 days, no enforcement hits, and no available latest-filing date. That combination preserves the strong enforcement profile while holding the filing-cadence subscore at 25.

The clearest rerating catalyst sits within regulatory, the highest-scoring pillar. POSaBIT already benefits from favorable jurisdiction and enforcement readings, leaving filing cadence as the principal variable capable of broadening regulatory confidence. A timely primary regulatory filing that provides current operating and financial disclosure would strengthen transparency, sharpen interpretation of the revenue decline and negative margins, and create a firmer basis for institutional pricing feeds and CIN newsroom coverage. The single most important signal to watch is the re-establishment of a current, consistent primary regulatory filing cadence.

Scored: 2026-10-14Valid through: 2026-11-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
CEO
Ryan Hamlin
CFO
Stephen Gledhill
SEC CIK
0001844459
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$8.1M
Enterprise value
$8.4M
Price to book
4.50
Price to sales
0.87
EV / EBITDA
-17.46
Revenue (TTM)
$9.3M
Gross profit (TTM)
$7.7M
EBITDA
$-1.2M
Operating margin
-10.3%
Profit margin
-12.5%
Rev growth YoY
-25.0%
Return on equity
-540.2%
Return on assets
-11.7%
Shares outstanding
162.2M
Insider ownership
34.4%
Beta
1.01
Full-time employees
35
GICS sector
Technology
GICS industry
Software - Application
Filings & DisclosuresPrimary sources
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for POSAF (POSAF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for POSAF (POSAF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for POSAF are maintained by Cannabis Investor News and refreshed throughout the trading day.